New stent aims to seal Post-Surgery leaks without another operation
NCT ID NCT06862479
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the Luso-Cor esophageal stent for closing leaks (fistulas) that can happen after weight-loss or cancer surgery on the stomach or esophagus. About 180 adults will be enrolled and their outcomes compared to those treated with standard stents or vacuum therapy. The goal is to see if the new stent is safer and more effective at sealing these leaks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Luso-Cor esophageal stent
What this could lead to
If it works, this could provide a safer, more effective way to close post-surgery leaks without additional surgery.
What could go wrong
This is a registry study, not a randomized trial, so results may be less conclusive. The stent may not outperform existing methods and could have complications like migration or blockage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Serviço de Gastrenterologia e Hepatologia, Unidade Local de Saúde Santa Maria
Lisbon, Lisbon District, 1649-035, Portugal